カテゴリ： 世界, 医療/バイオ, Market Monitor Global

抗感染症薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬

■ 英語タイトル：Drugs for Anti-Infective Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8486）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8486
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：121
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[抗感染症薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の抗感染症薬市場規模と予測を収録しています。・世界の抗感染症薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗感染症薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗感染症薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「OTC」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

抗感染症薬のグローバル主要企業は、GlaxoSmithKline、 Merck、 Pfizer、 Novartis AG、 Gilead Sciences、 Abbott、 Wyeth、 Sanofi-Aventis、 Bristol-Myers Squibb、 Johnson、 Roche Pharma AG、 Nanosphere、 NanoViricides、 Novabay Pharmaceuticals、 Obetech、 Optimer Pharmaceuticals、 Basilea Pharmaceutica AG、 Daiichi Sankyo、 MerLion Pharma、 Theravanceなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、抗感染症薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗感染症薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗感染症薬市場：タイプ別市場シェア、2022年
・OTC、Rx治療薬

世界の抗感染症薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗感染症薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の抗感染症薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗感染症薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗感染症薬のグローバル売上、2018年-2023年
・主要企業における抗感染症薬のグローバル売上シェア、2022年
・主要企業における抗感染症薬のグローバル販売量、2018年-2023年
・主要企業における抗感染症薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GlaxoSmithKline、 Merck、 Pfizer、 Novartis AG、 Gilead Sciences、 Abbott、 Wyeth、 Sanofi-Aventis、 Bristol-Myers Squibb、 Johnson、 Roche Pharma AG、 Nanosphere、 NanoViricides、 Novabay Pharmaceuticals、 Obetech、 Optimer Pharmaceuticals、 Basilea Pharmaceutica AG、 Daiichi Sankyo、 MerLion Pharma、 Theravance

*************************************************************

・調査・分析レポートの概要
抗感染症薬市場の定義
市場セグメント
世界の抗感染症薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗感染症薬市場規模
世界の抗感染症薬市場規模：2022年 VS 2029年
世界の抗感染症薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗感染症薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗感染症薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：OTC、Rx治療薬
抗感染症薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
抗感染症薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗感染症薬市場規模 2022年と2029年
地域別抗感染症薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GlaxoSmithKline、 Merck、 Pfizer、 Novartis AG、 Gilead Sciences、 Abbott、 Wyeth、 Sanofi-Aventis、 Bristol-Myers Squibb、 Johnson、 Roche Pharma AG、 Nanosphere、 NanoViricides、 Novabay Pharmaceuticals、 Obetech、 Optimer Pharmaceuticals、 Basilea Pharmaceutica AG、 Daiichi Sankyo、 MerLion Pharma、 Theravance
...

Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
This report aims to provide a comprehensive presentation of the global market for Drugs for Anti-Infective, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Anti-Infective. This report contains market size and forecasts of Drugs for Anti-Infective in global, including the following market information:
Global Drugs for Anti-Infective Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Drugs for Anti-Infective Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Drugs for Anti-Infective companies in 2022 (%)
The global Drugs for Anti-Infective market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
OTC Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Drugs for Anti-Infective include GlaxoSmithKline, Merck, Pfizer, Novartis AG, Gilead Sciences, Abbott, Wyeth, Sanofi-Aventis and Bristol-Myers Squibb, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Anti-Infective manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Anti-Infective Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Anti-Infective Market Segment Percentages, by Type, 2022 (%)
OTC
Rx Drugs
Global Drugs for Anti-Infective Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Anti-Infective Market Segment Percentages, by Application, 2022 (%)
Hospital
Drugs Store
Other
Global Drugs for Anti-Infective Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Drugs for Anti-Infective Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Anti-Infective revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Drugs for Anti-Infective revenues share in global market, 2022 (%)
Key companies Drugs for Anti-Infective sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Drugs for Anti-Infective sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Anti-Infective, market overview.
Chapter 2: Global Drugs for Anti-Infective market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs for Anti-Infective manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Anti-Infective in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs for Anti-Infective capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Drugs for Anti-Infective Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Anti-Infective Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Anti-Infective Overall Market Size
2.1 Global Drugs for Anti-Infective Market Size: 2022 VS 2029
2.2 Global Drugs for Anti-Infective Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Drugs for Anti-Infective Sales: 2018-2029
3 Company Landscape
3.1 Top Drugs for Anti-Infective Players in Global Market
3.2 Top Global Drugs for Anti-Infective Companies Ranked by Revenue
3.3 Global Drugs for Anti-Infective Revenue by Companies
3.4 Global Drugs for Anti-Infective Sales by Companies
3.5 Global Drugs for Anti-Infective Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Drugs for Anti-Infective Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Drugs for Anti-Infective Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Anti-Infective Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Anti-Infective Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Anti-Infective Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs for Anti-Infective Market Size Markets, 2022 & 2029
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type – Global Drugs for Anti-Infective Revenue & Forecasts
4.2.1 By Type – Global Drugs for Anti-Infective Revenue, 2018-2023
4.2.2 By Type – Global Drugs for Anti-Infective Revenue, 2024-2029
4.2.3 By Type – Global Drugs for Anti-Infective Revenue Market Share, 2018-2029
4.3 By Type – Global Drugs for Anti-Infective Sales & Forecasts
4.3.1 By Type – Global Drugs for Anti-Infective Sales, 2018-2023
4.3.2 By Type – Global Drugs for Anti-Infective Sales, 2024-2029
4.3.3 By Type – Global Drugs for Anti-Infective Sales Market Share, 2018-2029
4.4 By Type – Global Drugs for Anti-Infective Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs for Anti-Infective Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Drugs Store
5.1.4 Other
5.2 By Application – Global Drugs for Anti-Infective Revenue & Forecasts
5.2.1 By Application – Global Drugs for Anti-Infective Revenue, 2018-2023
5.2.2 By Application – Global Drugs for Anti-Infective Revenue, 2024-2029
5.2.3 By Application – Global Drugs for Anti-Infective Revenue Market Share, 2018-2029
5.3 By Application – Global Drugs for Anti-Infective Sales & Forecasts
5.3.1 By Application – Global Drugs for Anti-Infective Sales, 2018-2023
5.3.2 By Application – Global Drugs for Anti-Infective Sales, 2024-2029
5.3.3 By Application – Global Drugs for Anti-Infective Sales Market Share, 2018-2029
5.4 By Application – Global Drugs for Anti-Infective Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs for Anti-Infective Market Size, 2022 & 2029
6.2 By Region – Global Drugs for Anti-Infective Revenue & Forecasts
6.2.1 By Region – Global Drugs for Anti-Infective Revenue, 2018-2023
6.2.2 By Region – Global Drugs for Anti-Infective Revenue, 2024-2029
6.2.3 By Region – Global Drugs for Anti-Infective Revenue Market Share, 2018-2029
6.3 By Region – Global Drugs for Anti-Infective Sales & Forecasts
6.3.1 By Region – Global Drugs for Anti-Infective Sales, 2018-2023
6.3.2 By Region – Global Drugs for Anti-Infective Sales, 2024-2029
6.3.3 By Region – Global Drugs for Anti-Infective Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Drugs for Anti-Infective Revenue, 2018-2029
6.4.2 By Country – North America Drugs for Anti-Infective Sales, 2018-2029
6.4.3 US Drugs for Anti-Infective Market Size, 2018-2029
6.4.4 Canada Drugs for Anti-Infective Market Size, 2018-2029
6.4.5 Mexico Drugs for Anti-Infective Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Drugs for Anti-Infective Revenue, 2018-2029
6.5.2 By Country – Europe Drugs for Anti-Infective Sales, 2018-2029
6.5.3 Germany Drugs for Anti-Infective Market Size, 2018-2029
6.5.4 France Drugs for Anti-Infective Market Size, 2018-2029
6.5.5 U.K. Drugs for Anti-Infective Market Size, 2018-2029
6.5.6 Italy Drugs for Anti-Infective Market Size, 2018-2029
6.5.7 Russia Drugs for Anti-Infective Market Size, 2018-2029
6.5.8 Nordic Countries Drugs for Anti-Infective Market Size, 2018-2029
6.5.9 Benelux Drugs for Anti-Infective Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Drugs for Anti-Infective Revenue, 2018-2029
6.6.2 By Region – Asia Drugs for Anti-Infective Sales, 2018-2029
6.6.3 China Drugs for Anti-Infective Market Size, 2018-2029
6.6.4 Japan Drugs for Anti-Infective Market Size, 2018-2029
6.6.5 South Korea Drugs for Anti-Infective Market Size, 2018-2029
6.6.6 Southeast Asia Drugs for Anti-Infective Market Size, 2018-2029
6.6.7 India Drugs for Anti-Infective Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Drugs for Anti-Infective Revenue, 2018-2029
6.7.2 By Country – South America Drugs for Anti-Infective Sales, 2018-2029
6.7.3 Brazil Drugs for Anti-Infective Market Size, 2018-2029
6.7.4 Argentina Drugs for Anti-Infective Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Drugs for Anti-Infective Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Drugs for Anti-Infective Sales, 2018-2029
6.8.3 Turkey Drugs for Anti-Infective Market Size, 2018-2029
6.8.4 Israel Drugs for Anti-Infective Market Size, 2018-2029
6.8.5 Saudi Arabia Drugs for Anti-Infective Market Size, 2018-2029
6.8.6 UAE Drugs for Anti-Infective Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Drugs for Anti-Infective Major Product Offerings
7.1.4 GlaxoSmithKline Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Drugs for Anti-Infective Major Product Offerings
7.2.4 Merck Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Drugs for Anti-Infective Major Product Offerings
7.3.4 Pfizer Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Novartis AG
7.4.1 Novartis AG Company Summary
7.4.2 Novartis AG Business Overview
7.4.3 Novartis AG Drugs for Anti-Infective Major Product Offerings
7.4.4 Novartis AG Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.4.5 Novartis AG Key News & Latest Developments
7.5 Gilead Sciences
7.5.1 Gilead Sciences Company Summary
7.5.2 Gilead Sciences Business Overview
7.5.3 Gilead Sciences Drugs for Anti-Infective Major Product Offerings
7.5.4 Gilead Sciences Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.5.5 Gilead Sciences Key News & Latest Developments
7.6 Abbott
7.6.1 Abbott Company Summary
7.6.2 Abbott Business Overview
7.6.3 Abbott Drugs for Anti-Infective Major Product Offerings
7.6.4 Abbott Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.6.5 Abbott Key News & Latest Developments
7.7 Wyeth
7.7.1 Wyeth Company Summary
7.7.2 Wyeth Business Overview
7.7.3 Wyeth Drugs for Anti-Infective Major Product Offerings
7.7.4 Wyeth Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.7.5 Wyeth Key News & Latest Developments
7.8 Sanofi-Aventis
7.8.1 Sanofi-Aventis Company Summary
7.8.2 Sanofi-Aventis Business Overview
7.8.3 Sanofi-Aventis Drugs for Anti-Infective Major Product Offerings
7.8.4 Sanofi-Aventis Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.8.5 Sanofi-Aventis Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Drugs for Anti-Infective Major Product Offerings
7.9.4 Bristol-Myers Squibb Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 Johnson
7.10.1 Johnson Company Summary
7.10.2 Johnson Business Overview
7.10.3 Johnson Drugs for Anti-Infective Major Product Offerings
7.10.4 Johnson Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.10.5 Johnson Key News & Latest Developments
7.11 Roche Pharma AG
7.11.1 Roche Pharma AG Company Summary
7.11.2 Roche Pharma AG Drugs for Anti-Infective Business Overview
7.11.3 Roche Pharma AG Drugs for Anti-Infective Major Product Offerings
7.11.4 Roche Pharma AG Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.11.5 Roche Pharma AG Key News & Latest Developments
7.12 Nanosphere
7.12.1 Nanosphere Company Summary
7.12.2 Nanosphere Drugs for Anti-Infective Business Overview
7.12.3 Nanosphere Drugs for Anti-Infective Major Product Offerings
7.12.4 Nanosphere Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.12.5 Nanosphere Key News & Latest Developments
7.13 NanoViricides
7.13.1 NanoViricides Company Summary
7.13.2 NanoViricides Drugs for Anti-Infective Business Overview
7.13.3 NanoViricides Drugs for Anti-Infective Major Product Offerings
7.13.4 NanoViricides Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.13.5 NanoViricides Key News & Latest Developments
7.14 Novabay Pharmaceuticals
7.14.1 Novabay Pharmaceuticals Company Summary
7.14.2 Novabay Pharmaceuticals Business Overview
7.14.3 Novabay Pharmaceuticals Drugs for Anti-Infective Major Product Offerings
7.14.4 Novabay Pharmaceuticals Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.14.5 Novabay Pharmaceuticals Key News & Latest Developments
7.15 Obetech
7.15.1 Obetech Company Summary
7.15.2 Obetech Business Overview
7.15.3 Obetech Drugs for Anti-Infective Major Product Offerings
7.15.4 Obetech Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.15.5 Obetech Key News & Latest Developments
7.16 Optimer Pharmaceuticals
7.16.1 Optimer Pharmaceuticals Company Summary
7.16.2 Optimer Pharmaceuticals Business Overview
7.16.3 Optimer Pharmaceuticals Drugs for Anti-Infective Major Product Offerings
7.16.4 Optimer Pharmaceuticals Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.16.5 Optimer Pharmaceuticals Key News & Latest Developments
7.17 Basilea Pharmaceutica AG
7.17.1 Basilea Pharmaceutica AG Company Summary
7.17.2 Basilea Pharmaceutica AG Business Overview
7.17.3 Basilea Pharmaceutica AG Drugs for Anti-Infective Major Product Offerings
7.17.4 Basilea Pharmaceutica AG Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.17.5 Basilea Pharmaceutica AG Key News & Latest Developments
7.18 Daiichi Sankyo
7.18.1 Daiichi Sankyo Company Summary
7.18.2 Daiichi Sankyo Business Overview
7.18.3 Daiichi Sankyo Drugs for Anti-Infective Major Product Offerings
7.18.4 Daiichi Sankyo Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.18.5 Daiichi Sankyo Key News & Latest Developments
7.19 MerLion Pharma
7.19.1 MerLion Pharma Company Summary
7.19.2 MerLion Pharma Business Overview
7.19.3 MerLion Pharma Drugs for Anti-Infective Major Product Offerings
7.19.4 MerLion Pharma Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.19.5 MerLion Pharma Key News & Latest Developments
7.20 Theravance
7.20.1 Theravance Company Summary
7.20.2 Theravance Business Overview
7.20.3 Theravance Drugs for Anti-Infective Major Product Offerings
7.20.4 Theravance Drugs for Anti-Infective Sales and Revenue in Global (2018-2023)
7.20.5 Theravance Key News & Latest Developments
8 Global Drugs for Anti-Infective Production Capacity, Analysis
8.1 Global Drugs for Anti-Infective Production Capacity, 2018-2029
8.2 Drugs for Anti-Infective Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Anti-Infective Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Anti-Infective Supply Chain Analysis
10.1 Drugs for Anti-Infective Industry Value Chain
10.2 Drugs for Anti-Infective Upstream Market
10.3 Drugs for Anti-Infective Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Anti-Infective Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脂質代謝異常症治療薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬
  • 脂質代謝疾患治療薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬
  • 抗がん剤曝露評価サービスのグローバル市場展望 2023年-2029年：がん標的治療薬、免疫療法薬、その他
  • サラセミア&合併症治療薬のグローバル市場展望 2023年-2029年：サラセミアマイルド、サラセミア中等度、サラセミアメジャー
  • 原発性免疫不全薬のグローバル市場展望 2023年-2029年：サイトカイン、抗サイトカイン抗体、シグナル分子阻害剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8486 )"抗感染症薬のグローバル市場展望 2023年-2029年：OTC、Rx治療薬" (英文：Drugs for Anti-Infective Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。